For serious kidney disease: Doses of 10 to 20 mg/kg of L-carnitine given as a slow injection is FDA-approved for use for L-carnitine deficiency in people with serious kidney disease
The researchers hypothesize that although there are dozens of genes that affect the metabolism of carnitine in the body, each gene might have a small effect, but no one gene has a severe disabling effect, such as often occurs in the more severe forms of autism
Thyroiditis resulting from administration of excess iodine to hamsters with hyperplastic goiters
Across biochemical assays, cell culture models, and preclinical animal studies, mechanistic investigations have focused on how BPC-157 interacts with nitric oxide signaling, angiogenic regulation, cytoskeletal remodeling, and epithelial or connective tissue repair processes
and recommendations for promoting plant-based dietary patterns
developed more effective exosomes targeting M2 microglia called M2pep-ADSC-Exos